Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium channel subfamily K member 3 (KCNK3), commonly known as TASK-1, is a member of the two-pore domain potassium (K2P) channel family that mediates background leak currents essential for setting the resting membrane potential (UniProt: P48524). It is primarily expressed in the heart, lungs, and central nervous system, where it regulates cellular excitability and responds to physiological stimuli such as extracellular pH and oxygen levels (PubMed: 10903571). In the cardiovascular system, TASK-1 is a key determinant of atrial repolarization and pulmonary vascular tone, making it a significant factor in the pathogenesis of atrial fibrillation and pulmonary arterial hypertension (PubMed: 31554101, 23644490). Pharmacological inhibition of TASK-1 is being explored as a strategy to treat rhythm disorders by prolonging the atrial refractory period, while its activation is investigated for reducing pulmonary resistance. Drugs such as doxapram and various experimental small molecules (e.g., BAY 2586116) interact with the channel's pore or sensing domains to modulate its activity (IUPHAR/BPS Guide to Pharmacology). Understanding TASK-1's role in chemoreception also highlights its potential as a target for respiratory conditions like sleep apnea (PubMed: 32810011).
TASK-1 modulators typically function as pore blockers (inhibitors) to increase cellular excitability and prolong action potential duration, or as activators to hyperpolarize the membrane and reduce excitability (IUPHAR/BPS Guide to Pharmacology).
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel subfamily K member 3 (KCNK3) (TASK-1).